CD8A and neoplasm: Previous studies have suggested that TXNIP serves as a negative regulator of glucose metabolism in tumor cells (Sullivan et al. 2018; Wang and Chen 2021); however, its role in CD8+ T cell glucose metabolism remains unclear.